Bumper Offer - Urjas oil Just @ Rs. 1
Ramistar 1.25 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. The alternative uses of Ramistar 1.25 Tablet (10) have also been explained below.
The optimal dosage of Ramistar 1.25 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Ramistar 1.25 Tablet (10) include Confusion. Besides the aforementioned side effects, there are other adverse effects of Ramistar 1.25 Tablet (10) as well, which are listed below. Normally, these side effects of Ramistar 1.25 Tablet (10) are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Ramistar 1.25 Tablet (10) has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Ramistar 1.25 Tablet (10) related warnings talks about Ramistar 1.25 Tablet (10)'s effects on the liver, heart and kidney.
Ramistar 1.25 Tablet (10) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema, Heart Failure, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Ramistar 1.25 Tablet (10) have been discussed in the sections ahead.
Additionally, Ramistar 1.25 Tablet (10) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Ramistar 1.25 Tablet (10) is considered not safe while driving, and is not addictive.
Ramistar 1.25 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Ramistar 1.25 Tablet (10) is used -
Mild
Common
Is the use of Ramistar 1.25 Tablet (10) safe for pregnant women?
Ramistar should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ramistar 1.25 Tablet (10) safe during breastfeeding?
Ramistar may have very limited harmful effects for breastfeeding women.
What is the effect of Ramistar 1.25 Tablet (10) on the Kidneys?
Ramistar rarely affects the kidneys.
What is the effect of Ramistar 1.25 Tablet (10) on the Liver?
Ramistar has very mild side effects on the liver.
What is the effect of Ramistar 1.25 Tablet (10) on the Heart?
Ramistar may have mild side effects on the heart. Most people will never see any effect on the heart.
Ramistar 1.25 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramistar 1.25 Tablet (10) unless your doctor advises you to do so -
Is this Ramistar 1.25 Tablet (10) habit forming or addictive?
Ramistar 1.25 Tablet (10) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ramistar 1.25 Tablet (10) can make you feel drowsy.
Is it safe?
Ramistar 1.25 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Ramistar 1.25 Tablet (10) in mental disorders is not effective.
Interaction between Food and Ramistar 1.25 Tablet (10)
Taking Ramistar 1.25 Tablet (10) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ramistar 1.25 Tablet (10)
It is difficult to say anything about the effect of Ramistar 1.25 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
